Andy Willis, 51, was handed a lifeline after being diagnosed with prostate cancer By ETHAN ENNALS PUBLISHED: 17:50 EDT, 21 October 2023 | UPDATED: 21:08 EDT, 22 October 2023 A man given only years to live after he was diagnosed with aggressive and incurable prostate cancer is now close to being tumour-free just months after he began a revolutionary drug...
Ability to reverse cancer’s resistance to therapy opens possibility of treatment for late-diagnosed men Andrew Gregory Health editor Scientists say a new way to treat prostate cancer may be on the horizon after finding it is possible to reverse its resistance to therapy. More than a million men worldwide are diagnosed with the disease each year....
by Lisette Hilton, University of Miami Dr. Bruno Nahar says his experience with HIFU has taught him the importance of patient selection, as the procedure isn’t “one size fits all.” Credit: Desai Sethi Urology InstituteFor Bruno Nahar, M.D., urological oncologist at Sylvester Comprehensive Cancer Center and Desai Sethi Urology Institute, performing the 150th focal high-intensity focused...
by American Cancer Society (ACS) Credit: CC0 Public DomainProstate cancer is the second leading cause of cancer death among men in the United States. According to the latest research from scientists at the American Cancer Society (ACS), more than 288,000 men will be diagnosed with the disease this year, with close to 35,000 deaths. Black...
by University College London pet scanCredit: CC0 Public DomainThe REIMAGINE study, published today in BMJ Oncology, is the first study to use MRI scans with prostate specific antigen (PSA) density to assess the need for further standard NHS tests. Of the 29 participants found to have serious prostate cancer, 15 had a ‘low’ PSA score...
By Paul McClure August 14, 2023 Researchers have uncovered the pathway that leads to an aggressive form of prostate cancer and a potential treatment for it Depositphotos Researchers have uncovered the molecular mechanism that drives an aggressive form of prostate cancer that doesn’t respond well to typical treatments. Importantly, they also identified a drug currently undergoing...
by American Chemical Society Prostate cancer cells. Credit: NIH Image Gallery To explore why prostate cancer disproportionately sickens and kills Black men, researchers are looking to another disorder, diabetes, which alters metabolism. They used this approach in a preliminary clinical trial and today report the identification of four metabolism-related biomarkers linked to an increased risk of metastatic prostate...
AMERICAN CHEMICAL SOCIETY Prostate cancer is a leading cause of death among American men, and it’s resistant to one of the most powerful chemotherapy medications — cisplatin. Now, researchers reporting in ACS Central Science have developed the first therapy of its kind that disrupts prostate cancer cells’ metabolism and releases cisplatin into the weakened cells,...
by Elana Gotkine For patients with metastatic castration-resistant prostate cancer (mCRPC), talazoparib plus enzalutamide results in improvement in radiographic progression-free survival (rPFS), according to a study published online June 4 in The Lancet to coincide with the annual meeting of the American Society of Clinical Oncology, held from June 2 to 6 in Chicago. Neeraj Agarwal, M.D., from the...
by University of Connecticut Credit: Pixabay/CC0 Public Domain Prostate cancer is the most common non-skin cancer in men worldwide. According to international estimates about one in six men will get prostate cancer during their lifetime and worldwide, over 375,000 patients will die from it each year. Tumor resistance to current therapies plays an essential role in...
